OSTEOARTHRITIS AND JOINT HEALTH: INNOVATION AND SUPPORT WITH ARTRODIFF PLUS®

Osteoarthritis is a chronic joint condition that causes cartilage wear, pain, stiffness, and limited movement. Modern joint care combines professional monitoring, healthy lifestyle habits, and science-based support strategies.

With a focus on innovation and an exclusive formulation, Diffucap developed ARTRODIFF PLUS®, designed to support joint health and mobility.


What is osteoarthritis and what are the main risk factors?

Osteoarthritis primarily affects the knees, hips, hands, and spine. It is not linked only to aging — it may also be associated with:

  • mechanical overload

  • previous joint injuries

  • excess body weight

  • inflammatory processes

  • oxidative stress

These factors contribute to progressive joint wear and functional discomfort.


Osteoarthritis management: an integrated approach is the reference standard

Joint health management involves combined actions, such as:

  • guided physical activity

  • muscle strengthening

  • weight control

  • patient education

In addition, the use of nutritional support with ingredients studied for joint inflammation and cartilage integrity has been growing.


ARTRODIFF PLUS®: exclusive combination for joint support

ARTRODIFF PLUS® brings together an exclusive combination of scientifically supported ingredients for joint health:

  • Undenatured Type II Collagen (UC-II®)

  • Oral Hyaluronic Acid

  • MSM

  • Turmeric

  • Chelated Magnesium

  • Astaxanthin

The formulation was developed for synergistic action in supporting cartilage, inflammatory response, and joint mobility.


Innovation and science applied to continuous care

A reference in pharmaceutical innovation, Diffucap invests in exclusive combinations and formulation technology to expand joint care strategies. ARTRODIFF PLUS® can be used as an ally within an individualized plan, with professional guidance.

This content does not replace consultation with a healthcare professional. Please consult your physician.